1. Home
  2. KRON

as 05-30-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.

Founded: 2017 Country:
United States
United States
Employees: N/A City: SAN MATEO
Market Cap: 41.0M IPO Year: 2020
Target Price: $1.63 AVG Volume (30 days): 925.7K
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.07 EPS Growth: N/A
52 Week Low/High: $0.65 - $1.60 Next Earning Date: 06-10-2025
Revenue: $9,192,000 Revenue Growth: 21.16%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

KRON Daily Stock ML Predictions

Share on Social Networks: